Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
APTX

APTX - Aptinyx Inc Stock Price, Fair Value and News

0.10USD Market Closed
Watchlist

Market Summary

USD0.10
Market Closed

APTX Stock Price

View Fullscreen

APTX RSI Chart

APTX Valuation

Market Cap

6.8M

Price/Earnings (Trailing)

-0.1

Price/Sales (Trailing)

6.77

Price/Free Cashflow

-0.12

APTX Price/Sales (Trailing)

APTX Profitability

Return on Equity

-362.01%

Return on Assets

-137.79%

Free Cashflow Yield

-817.23%

APTX Fundamentals

APTX Revenue

Revenue (TTM)

1.0M

APTX Earnings

Earnings (TTM)

-66.1M

Breaking Down APTX Revenue

Last 7 days

11.1%

Last 30 days

66.7%

Last 90 days

-86.4%

Trailing 12 Months

-70.4%

How does APTX drawdown profile look like?

APTX Financial Health

Current Ratio

5.12

Debt/Equity

1.07

Debt/Cashflow

-2.84

APTX Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20211.7M1.3M1.0M1.0M
20203.6M3.2M2.5M1.6M
20195.0M3.8M3.8M3.7M
20185.4M5.8M6.2M6.6M
20170005.0M

Tracking the Latest Insider Buys and Sells of Aptinyx Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 13, 2022
miller joan w.
bought
50,091
2.83
17,700
-
Dec 06, 2021
riedel norbert g
bought
223,000
2.23
100,000
ceo
Dec 02, 2021
khanna ashish
bought
101,700
2.26
45,000
cfo and cbo
Nov 12, 2021
hombach robert j.
bought
179,040
2.4
74,600
-
Nov 11, 2021
hombach robert j.
bought
12,960
2.4
5,400
-
May 17, 2021
riedel norbert g
acquired
-
-
380,000
ceo
May 17, 2021
riedel norbert g
sold (taxes)
-322,003
2.53
-127,274
ceo
May 17, 2021
khanna ashish
sold (taxes)
-96,367
2.53
-38,090
cfo and cbo

1–10 of 34

Which funds bought or sold APTX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jan 11, 2024
NORTHWESTERN UNIVERSITY
sold off
-100
-7,000
-
-%

1–1 of 1

Are Funds Buying or Selling APTX?

Are funds buying APTX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own APTX
No. of Funds

Unveiling Aptinyx Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2024
artal international s.c.a.
0%
0
SC 13G/A
Jun 27, 2023
adams street partners llc
8.0%
5,395,996
SC 13D/A
Mar 16, 2023
longitude capital partners ii, llc
0%
0
SC 13D/A
Feb 14, 2023
longitude capital partners ii, llc
5.0%
3,356,746
SC 13D/A
Feb 13, 2023
artal international s.c.a.
9.0%
6,116,493
SC 13G/A
Jan 20, 2023
kryzanowski john a
9.8%
6,637,800
SC 13G/A
Jun 24, 2022
kryzanowski john a
5.77%
1,942,680
SC 13G/A
Jun 24, 2022
kryzanowski john a
7.42%
4,695,800
SC 13G/A
Jun 24, 2022
kryzanowski john a
8.70%
5,890,802
SC 13G/A
Jun 24, 2022
kryzanowski john a
5.10%
1,781,291
SC 13G

Recent SEC filings of Aptinyx Inc

View All Filings
Date Filed Form Type Document
Feb 09, 2024
SC 13G/A
Major Ownership Report
Dec 21, 2023
8-K
Current Report
Dec 18, 2023
8-K
Current Report

Peers (Alternatives to Aptinyx Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
37.9B
9.1B
-16.59% -47.80%
-10.94
4.16
-57.36% -129.46%
32.0B
-
-0.77% 465779.94%
-3.7K
218.4K
- -102.45%
20.5B
1.8B
-23.99% -31.71%
-46.58
11.22
76.23% 61.08%
16.9B
2.3B
-4.89% -18.90%
115.27
7.33
15.05% 75.21%
13.7B
3.7B
-7.62% -26.87%
22.88
3.7
8.87% 75.42%
MID-CAP
8.0B
272.9M
-2.06% 34.31%
-13.22
29.35
141.38% 4.43%
6.5B
-
-3.85% 226.12%
-10.45
60.35
54.84% -25.61%
4.1B
631.9M
-12.60% 32.37%
-27.42
6.46
23.54% 31.53%
3.8B
223.4M
8.92% 47.81%
-18.87
17.04
-35.86% -26.24%
3.7B
240.7M
-19.08% -10.99%
-12.61
15.54
-1.03% -92.09%
SMALL-CAP
1.5B
348.4M
-3.38% -9.50%
23.89
4.25
81.69% -7.29%
579.7M
1.0B
-9.17% -57.89%
-1.06
0.55
-43.15% 58.48%
174.3M
4.9M
-14.18% -58.18%
-1.06
35.65
-57.57% 50.48%
112.6M
881.7K
289.54% 381.25%
-2.37
112.79
-77.61% -13.74%
4.2M
2.1M
7.69% 44.16%
-0.08
2.14
-13.45% 11.54%

Aptinyx Inc News

Latest updates
Investing.com9 months ago
InvestorPlace12 months ago
The Motley Fool5 years ago

Aptinyx Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q2
Revenue----1,000-2574908189189369258901,0399432,1282,4641,8351,2051,428
Operating Expenses-9.6%19,17221,20619,86615,29011,56111,68013,13515,95415,13116,28413,65218,21515,74915,73215,70814,273-9,3859,469
  S&GA Expenses3.8%5,1164,9285,0704,9764,7755,0504,7704,8994,5334,5234,1715,7254,8213,7822,0222,049-1,3181,268
  R&D Expenses-13.7%14,05616,27814,79610,3146,7866,6308,36511,05510,59811,7619,48112,49010,92811,95013,68612,224-8,0678,201
Interest Expenses-100.0%-72.00-----------------
Net Income7.6%-19,610-21,231-19,819-14,226-11,488-11,338-12,517-14,710-13,778-14,790-12,131-16,711-14,093-14,181-13,335-11,672--8,145-7,999
Net Income Margin-12.2%-74.89*-66.76*-45.24*-28.37*-31.98*-21.08*-17.65*------------
Free Cashflow-2.4%-19,060-18,610-16,771-8,984-7,913-13,277-9,816------------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q1
Assets-28.1%48.0067.0076.0092.00107115133134153151114121127106120130141156170183140
  Current Assets-25.4%48.0064.0074.0092.00107115132134152150113120126105119128139153168180-
    Cash Equivalents-20.7%45.0056.0067.0085.0010010612512914714110411612199.0011512513715116618083.00
  Net PPE-100.0%-0.000.000.000.000.000.000.000.001.001.001.001.001.001.001.002.002.002.002.00-
Liabilities4.6%30.0028.0027.0030.0029.0020.0021.003.004.005.004.004.005.005.007.005.006.006.008.008.006.00
  Current Liabilities48.2%9.006.003.006.005.006.006.003.004.005.004.004.005.005.007.005.006.006.008.007.00-
  Long Term Debt-12.0%19.0022.0025.0024.0024.0014.0014.00--------------
    LT Debt, Current102.3%6.003.00-------------------
    LT Debt, Non Current-12.0%19.0022.0025.0024.0024.0014.0014.00--------------
Shareholder's Equity-52.3%18.0038.0049.0062.0077.0095.0011213114914611011712310111312513514916217613.00
  Retained Earnings-6.0%-373-352-340-325-307-287-268-247-227-213-201-190-177-162-149-134-122-105-91.44-77.26-
  Additional Paid-In Capital0.3%391390389387385382380377375358311307300264262259257255253252-
Shares Outstanding0%68.0068.0068.0068.0068.0068.0068.0067.0066.0063.0047.0046.00---------
Float----38*---136---195---62.00---368-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q1
Cashflow From Operations-9.5%-11,365-10,377-18,625-14,758-15,924-19,060-18,610-16,771-8,984-7,913-13,098-9,792-11,553-15,460-10,697-11,787-14,143-14,983-12,255-10,774-9,436
  Share Based Compensation-32.9%1,0371,5451,9962,2812,3502,3242,2622,4782,6552,4762,6692,5032,3312,0702,6412,3252,0001,334720740524
Cashflow From Investing-------1.001.0031.0090.00--179-24.00-11.004.00----16.00-69.00-276-46.00
Cashflow From Financing-13250.0%-267-2.00-78.00-1339,960-10514,599-84414,67645,1311,1354,67433,73591.00-12614186.0058.00-1,170107,790-304

APTX Income Statement

2023-03-31
Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:  
Research and development$ 16,093$ 13,602
General and administrative4,2295,777
Total operating expenses20,32219,379
Loss from operations(20,322)(19,379)
Other (income) expense, net(286)(29)
Interest expense1,030477
Net loss and comprehensive loss$ (21,066)$ (19,827)
Net loss per share attributable to common stockholders, basic (in dollars per share)$ (0.31)$ (0.29)
Net loss per share attributable to common stockholders, diluted (in dollars per share)$ (0.31)$ (0.29)
Weighted-average number of common shares outstanding, basic (in shares)67,71667,716
Weighted-average number of common shares outstanding, diluted (in shares)67,71667,716

APTX Balance Sheet

2023-03-31
Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 44,573$ 56,205
Short-term restricted cash179179
Prepaid expenses and other current assets3,0057,646
Total current assets47,75764,030
Other assets2062,622
Property and equipment, net 32
Total assets47,96366,684
Current liabilities:  
Accounts payable1,374724
Accrued expenses and other current liabilities1,1572,772
Finance lease, current1,138 
Term loan, current5,6542,795
Total current liabilities9,3236,291
Finance lease, non-current940 
Term loan, non-current19,44422,108
Total liabilities29,70728,399
Commitments and contingencies (see Note 12)
Stockholders' equity:  
Preferred stock, $0.01 par value, 10,000 shares authorized and no shares issued and outstanding as of March 31, 2023 and December 31, 2022
Common stock, $0.01 par value, 150,000 shares authorized as of March 31, 2023 and December 31, 2022, 67,716 issued and outstanding as of March 31, 2023 and December 31, 2022677677
Additional paid-in capital391,381390,344
Accumulated deficit(373,802)(352,736)
Total stockholders' equity18,25638,285
Total liabilities and stockholders' equity$ 47,963$ 66,684
APTX
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
 WEBSITEwww.aptinyx.com
 EMPLOYEES12

Aptinyx Inc Frequently Asked Questions


What is the ticker symbol for Aptinyx Inc? What does APTX stand for in stocks?

APTX is the stock ticker symbol of Aptinyx Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aptinyx Inc (APTX)?

As of Fri Dec 29 2023, market cap of Aptinyx Inc is 6.77 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of APTX stock?

You can check APTX's fair value in chart for subscribers.

What is the fair value of APTX stock?

You can check APTX's fair value in chart for subscribers. The fair value of Aptinyx Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aptinyx Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for APTX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aptinyx Inc a good stock to buy?

The fair value guage provides a quick view whether APTX is over valued or under valued. Whether Aptinyx Inc is cheap or expensive depends on the assumptions which impact Aptinyx Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for APTX.

What is Aptinyx Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 29 2023, APTX's PE ratio (Price to Earnings) is -0.1 and Price to Sales (PS) ratio is 6.77. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. APTX PE ratio will change depending on the future growth rate expectations of investors.